Insider Trading History of Collier Alan Brian


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Collier Alan Brian since year 2005. The trader's CIK number is 1645470. At the time of the last reporting, Collier Alan Brian was the CEO of Endonovo Therapeutics, Inc. . (stock ticker symbol ENDV). See this page for all insider trading activities at Endonovo Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Collier Alan Brian since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-04-11 ENDV Endonovo Therapeutics, Inc. Buy 2,000 .02 34
2019-04-12 ENDV Endonovo Therapeutics, Inc. Buy 4,000 .02 68
2019-04-10 ENDV Endonovo Therapeutics, Inc. Buy 7,500 .02 127
2019-04-03 ENDV Endonovo Therapeutics, Inc. Buy 4,000 .02 72
2019-03-29 ENDV Endonovo Therapeutics, Inc. Buy 22,000 .02 374
2019-04-01 ENDV Endonovo Therapeutics, Inc. Buy 1,000 .02 17
2019-03-28 ENDV Endonovo Therapeutics, Inc. Buy 5,000 .02 90
2019-03-27 ENDV Endonovo Therapeutics, Inc. Buy 4,000 .02 72
2019-03-26 ENDV Endonovo Therapeutics, Inc. Buy 3,000 .02 53
2019-03-27 ENDV Endonovo Therapeutics, Inc. Buy 4,000 .02 72
2019-03-25 ENDV Endonovo Therapeutics, Inc. Buy 47,000 .02 845
2019-03-13 ENDV Endonovo Therapeutics, Inc. Buy 2,500 .02 47
2019-03-18 ENDV Endonovo Therapeutics, Inc. Buy 20,000 .02 400
2019-03-15 ENDV Endonovo Therapeutics, Inc. Buy 25,000 .02 500
2019-03-14 ENDV Endonovo Therapeutics, Inc. Buy 7,000 .02 140
2019-03-08 ENDV Endonovo Therapeutics, Inc. Buy 7,000 .02 140
2019-03-11 ENDV Endonovo Therapeutics, Inc. Buy 12,000 .02 228
2019-03-12 ENDV Endonovo Therapeutics, Inc. Buy 2,000 .02 38
2019-03-07 ENDV Endonovo Therapeutics, Inc. Buy 10,000 .02 200
2019-03-05 ENDV Endonovo Therapeutics, Inc. Buy 31,500 .02 661
2019-03-06 ENDV Endonovo Therapeutics, Inc. Buy 62,000 .02 1,178
2019-03-04 ENDV Endonovo Therapeutics, Inc. Buy 15,000 .02 315
2019-02-27 ENDV Endonovo Therapeutics, Inc. Buy 21,500 .02 430
2019-02-28 ENDV Endonovo Therapeutics, Inc. Buy 5,000 .02 105
2019-03-01 ENDV Endonovo Therapeutics, Inc. Buy 5,000 .02 105
2019-02-19 ENDV Endonovo Therapeutics, Inc. Buy 30,000 .02 690
2019-02-20 ENDV Endonovo Therapeutics, Inc. Buy 10,000 .02 240
2019-02-21 ENDV Endonovo Therapeutics, Inc. Buy 10,000 .02 230
2019-02-15 ENDV Endonovo Therapeutics, Inc. Buy 114,000 .02 2,622
2019-02-14 ENDV Endonovo Therapeutics, Inc. Buy 60,000 .02 1,320
2019-02-15 ENDV Endonovo Therapeutics, Inc. Buy 17,000 .02 391
2019-02-12 ENDV Endonovo Therapeutics, Inc. Buy 17,500 .02 385
2019-02-12 ENDV Endonovo Therapeutics, Inc. Buy 213,000 .02 4,899
2019-02-06 ENDV Endonovo Therapeutics, Inc. Buy 15,000 .03 390
2019-02-07 ENDV Endonovo Therapeutics, Inc. Buy 23,000 .03 598
2019-01-30 ENDV Endonovo Therapeutics, Inc. Buy 30,000 .03 780
2019-01-31 ENDV Endonovo Therapeutics, Inc. Buy 16,000 .03 416
2019-01-29 ENDV Endonovo Therapeutics, Inc. Buy 27,000 .03 729
2019-01-28 ENDV Endonovo Therapeutics, Inc. Buy 32,000 .03 928
2019-01-22 ENDV Endonovo Therapeutics, Inc. Buy 50,500 .03 1,313
2019-01-23 ENDV Endonovo Therapeutics, Inc. Buy 15,000 .03 390
2019-01-24 ENDV Endonovo Therapeutics, Inc. Buy 10,000 .03 280
2019-01-25 ENDV Endonovo Therapeutics, Inc. Buy 45,000 .03 1,305
2019-01-17 ENDV Endonovo Therapeutics, Inc. Buy 15,000 .03 450
2019-01-22 ENDV Endonovo Therapeutics, Inc. Buy 50,500 .03 1,313
2019-01-15 ENDV Endonovo Therapeutics, Inc. Buy 121,500 .03 3,888
2019-01-16 ENDV Endonovo Therapeutics, Inc. Buy 40,000 .03 1,200
2019-01-14 ENDV Endonovo Therapeutics, Inc. Buy 45,000 .03 1,485
2019-01-09 ENDV Endonovo Therapeutics, Inc. Buy 45,000 .02 855
2016-06-20 ENDV Endonovo Therapeutics, Inc. Buy 1,000,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Collier Alan Brian (CEO of Endonovo Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.